SC
DGX icon

Syon Capital’s Quest Diagnostics DGX Stock Holding History

Syon Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$762K Buy
3,595
+728
+25% +$143K 0.03% 457
2026
Q1 		$562K Sell
2,867
-1,200
-30% -$233K 0.03% 508
2025
Q4 		$706K Buy
4,067
+836
+26% +$152K 0.04% 425
2025
Q3 		$616K Buy
3,231
+1,786
+124% +$317K 0.03% 413
2025
Q2 		$260K Buy
1,445
+54
+4% +$9.38K 0.02% 600
2025
Q1 		$235K Buy
+1,391
New +$229K 0.02% 497

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Syon Capital's DGX Position: Q2 2026 in Review

Syon Capital increased its Quest Diagnostics (DGX) stake by 25% in Q2 2026, buying an estimated $143K and bringing the position to 3,595 shares worth $762K. The position accounts for 0.03% of the portfolio, ranked #457.

Syon Capital first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Syon Capital held 3,595 shares of Quest Diagnostics worth $762K as of Q2 2026.
  • Syon Capital bought 728 Quest Diagnostics shares in Q2 2026, an estimated $143K.
  • Quest Diagnostics made up 0.03% of Syon Capital's portfolio in Q2 2026, its #457 holding.
  • Syon Capital first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.